The Patent Finder

Keros Therapeutics, Inc.

Also on record
Records under this name other than the patents Keros Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 18 patents it holds.

Back to Keros Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
17/945,324Methods of Using Activin Receptor Type Iia Variants
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/128,465Methods of Using Activin Receptor Type II Variants
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/140,141Methods of Treating Lymphopenia
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/289,037Activin Receptor Type II Chimeras and Methods of Use Thereof
Abandoned
Abandoned Oct 12, 2026
AbandonedAbandoned Oct 12, 2026
18/289,039Methods of Using ALK2 and ALK3 Antibodies
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/390,085Methods of Using Activin Receptor Type II Signaling Inhibitors
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/443,987Methods of Using Activin Receptor Type II Signaling Inhibitors
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/706,647Methods of Using ALK2 Inhibitors
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/067,565Methods of Administering an Activin Receptor Type Iib Variant
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/077,471Activin Receptor Type Iib Variants and Methods of Use Thereof
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
10 of 21 records shown.
Pro members see all 21.
Pro members: see all 21 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited